Company Filing History:
1 out of 1,168 
1 out of 1 Years Active: 2010
Title: Rivka Abulafia-Lapid: Innovator in HIV Treatment
Introduction
Rivka Abulafia-Lapid is a prominent inventor based in Yahud, Israel. She has made significant contributions to the field of medical research, particularly in the treatment of HIV infection. Her innovative approach has led to the development of a unique T cell vaccine aimed at improving the lives of immunodeficient HIV-infected patients.
Latest Patents
Rivka holds 1 patent for her groundbreaking work titled "Inactivated CD8+ T-cells for the treatment of HIV infection." This patent describes a method for preparing a T cell vaccine that enriches autologous CD4-reactive CD8 T cells. The protocol outlined in her patent provides a comprehensive approach for implementing T cell vaccination in immunodeficient HIV-infected individuals. Additionally, the patent includes methods for treatment based on the developed T cell vaccine, along with kits for preparing the vaccine and implementing the vaccination protocol.
Career Highlights
Throughout her career, Rivka has worked with notable organizations, including Yeda Research and Development Company and Hadasit Medical Research Services and Development Ltd. Her work has been instrumental in advancing research and development in the medical field, particularly concerning HIV treatment.
Collaborations
Rivka has collaborated with esteemed colleagues such as Henri Atlan and Irun R Cohen. These partnerships have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Rivka Abulafia-Lapid's contributions to HIV treatment through her patented T cell vaccine exemplify her dedication to medical innovation. Her work continues to inspire advancements in the field and offers hope for improved treatment options for those affected by HIV.